Scaling up context-tailored clinical guidelines and training to improve childbirth care in urban, low-resource maternity units in Tanzania: A protocol for a stepped-wedged cluster randomized trial with embedded qualitative and economic analyses (The PartoMa Scale-Up Study).
Africa
Obstetrics
co-creation
cost-effectiveness
de-colonizing
intervention
low dose high frequency training
perinatal death
programme theory
respectful maternity care
stillbirth
urbanization
Journal
Global health action
ISSN: 1654-9880
Titre abrégé: Glob Health Action
Pays: United States
ID NLM: 101496665
Informations de publication
Date de publication:
31 12 2022
31 12 2022
Historique:
entrez:
12
4
2022
pubmed:
13
4
2022
medline:
14
4
2022
Statut:
ppublish
Résumé
While facility births are increasing in many low-resource settings, quality of care often does not follow suit; maternal and perinatal mortality and morbidity remain unacceptably high. Therefore, realistic, context-tailored clinical support is crucially needed to assist birth attendants in resource-constrained realities to provide best possible evidence-based and respectful care. Our pilot study in Zanzibar suggested that co-created clinical practice guidelines (CPGs) and low-dose, high-frequency training (PartoMa intervention) were associated with improved childbirth care and survival. We now aim to modify, implement, and evaluate this multi-faceted intervention in five high-volume, urban maternity units in Dar es Salaam, Tanzania (approximately 60,000 births annually). This PartoMa Scale-up Study will include four main steps: I. Mixed-methods situational analysis exploring factors affecting care; II. Co-created contextual modifications to the pilot CPGs and training, based on step I; III. Implementation and evaluation of the modified intervention; IV. Development of a framework for co-creation of context-specific CPGs and training, of relevance in comparable fields. The implementation and evaluation design is a theory-based, stepped-wedged cluster-randomised trial with embedded qualitative and economic assessments. Women in active labour and their offspring will be followed until discharge to assess provided and experienced care, intra-hospital perinatal deaths, Apgar scores, and caesarean sections that could potentially be avoided. Birth attendants' perceptions, intervention use and possible associated learning will be analysed. Moreover, as further detailed in the accompanying article, a qualitative in-depth investigation will explore behavioural, biomedical, and structural elements that might interact with non-linear and multiplying effects to shape health providers' clinical practices. Finally, the incremental cost-effectiveness of co-creating and implementing the PartoMa intervention is calculated. Such real-world scale-up of context-tailored CPGs and training within an existing health system may enable a comprehensive understanding of how impact is achieved or not, and how it may be translated between contexts and sustained.Trial registration number: NCT04685668.
Identifiants
pubmed: 35410590
doi: 10.1080/16549716.2022.2034135
pmc: PMC9009913
doi:
Banques de données
ClinicalTrials.gov
['NCT04685668']
Types de publication
Clinical Trial Protocol
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2034135Références
Acta Obstet Gynecol Scand. 2012 Sep;91(9):1069-76
pubmed: 22642620
Glob Health Action. 2016 Dec 02;9:33163
pubmed: 27924741
Lancet Glob Health. 2021 Jun;9(6):e875-e879
pubmed: 33765437
Global Health. 2016 Dec 20;12(1):86
pubmed: 27998288
Int J Gynaecol Obstet. 2019 Jan;144(1):27-36
pubmed: 30307609
Bull World Health Organ. 2019 May 01;97(5):365-370
pubmed: 31551633
J Glob Health. 2016 Jun;6(1):010508
pubmed: 26401272
Lancet. 2019 Nov 9;394(10210):1750-1763
pubmed: 31604660
BMJ Glob Health. 2021 Jan;6(1):
pubmed: 33479018
BMJ. 2010 Mar 23;340:c869
pubmed: 20332511
BMJ. 2017 Mar 6;356:i6795
pubmed: 28264797
Res Involv Engagem. 2019 Jan 09;5:2
pubmed: 30652027
Lancet Glob Health. 2017 Sep;5(9):e855-e856
pubmed: 28807174
Lancet. 2016 Feb 13;387(10019):703-716
pubmed: 26794079
Lancet. 2014 Nov 15;384(9956):1775-88
pubmed: 25455248
Milbank Mem Fund Q. 1966 Jul;44(3):Suppl:166-206
pubmed: 5338568
Lancet. 2016 Nov 5;388(10057):2296-2306
pubmed: 27642020
Reprod Health. 2016 Jul 18;13(1):79
pubmed: 27424608
Lancet. 2020 Sep 19;396(10254):816-817
pubmed: 32950087
Lancet Glob Health. 2015 Jul;3(7):e396-409
pubmed: 26087986
BMC Pregnancy Childbirth. 2017 Jun 7;17(1):175
pubmed: 28592237
Lancet. 2018 Nov 17;392(10160):2214-2228
pubmed: 30314860
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Lancet Glob Health. 2021 Jun;9(6):e759-e772
pubmed: 33811827
Lancet. 2016 Oct 29;388(10056):2176-2192
pubmed: 27642019
BJOG. 2018 Jan;125(2):235-245
pubmed: 28892306
Lancet. 2021 Aug 28;398(10302):772-785
pubmed: 34454675
Lancet. 2016 Oct 29;388(10056):2193-2208
pubmed: 27642023
Reprod Health. 2020 Mar 14;17(1):36
pubmed: 32171296
Sex Transm Infect. 2017 Jul;93(Suppl 3):
pubmed: 28736396
Glob Health Action. 2022 Dec 31;15(1):2034136
pubmed: 35311627
BMC Pregnancy Childbirth. 2016 Aug 19;16:236
pubmed: 27543002
Lancet. 2016 Dec 3;388(10061):2811-2824
pubmed: 27072119
Lancet Glob Health. 2020 Jul;8(7):e901-e908
pubmed: 32405459
Trials. 2015 Aug 17;16:352
pubmed: 26279154
Lancet. 2018 Nov 10;392(10159):1859-1922
pubmed: 30415748
Lancet. 2016 Nov 5;388(10057):2307-2320
pubmed: 27642018
Lancet Glob Health. 2020 Oct;8(10):e1259
pubmed: 32758433
Lancet. 2019 May 11;393(10184):1973-1982
pubmed: 30929893
BJOG. 2012 Apr;119(5):605-13
pubmed: 22329559
Pediatr Res. 2013 Dec;74 Suppl 1:50-72
pubmed: 24366463
BJOG. 2018 Jul;125(8):991-1000
pubmed: 29498187
Health Serv Res. 2013 Dec;48(6 Pt 2):2134-56
pubmed: 24279835
Reprod Health. 2018 Jan 10;15(1):8
pubmed: 29321051